Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Bioinformatic Evaluation of Molecular Differences in HLA-B and Their Effect on Graft-Versus-Host Disease in Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation from Related Donors

Michelle Morcos, Alexia Gonzalez, Héctor Alejandro Vaquera Alfaro, Dalila Marisol Alvarado-Navarro, Perla R. Rocio Colunga-Pedraza, Andres Gomez-De Leon, Rosario Salazar-Riojas, Maria Luisa Aguilar-Escobedo, Luis Paulo Ugarte Pelaez, Francisco Javier Rubio Macias, Olga Cantu, David Gomez-Almaguer, Nidia Karina Moncada Saucedo

Blood (2024) 144 (Supplement 1): 7514.

https://doi.org/10.1182/blood-2024-208823

Published: 2024

Journal Articles

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Gerardo Garcia-Salas, David Gomez-Almaguer, Carlos Reta-Cortéz, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, José Carlos Jaime-Pérez, César Homero Gutierrez-Aguirre, Luz Tarin-Arzaga, Perla Colunga-Pedraza, Olga Cantu, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 7119.

https://doi.org/10.1182/blood-2024-210532

Published: 2024

Journal Articles

Reassessing Blood Product Irradiation in Haploidentical Transplantation: A Single-Center Perspective

Juan Pablo Martinez, Yesica Aylen López-Mora, Rosario Salazar-Riojas, Dalila Marisol Alvarado-Navarro, Ana Karen Hernández-Navarro, Yair Omar Chávez-Estrada, Andres Gomez-De Leon, César Homero Gutierrez-Aguirre, Perla R. Rocio Colunga-Pedraza, Olga Cantu, José Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 4030.

https://doi.org/10.1182/blood-2024-205373

Published: 2024

Journal Articles

Lowering Conditioning Intensity in Fit Adolescents and Adults with Lymphoblastic Leukemia without Residual Disease Undergoing Transplantation: A Proof of Concept

Alexia Gonzalez, Ana Laura Varela Constantino, Nereida Méndez-Ramírez, Fernando J Medina-Olivares, Eli Fuentes-Chavez, Rosario Salazar-Riojas, César Homero Gutierrez-Aguirre, Olga Cantu, Perla Colunga-Pedraza, Luz Tarin-Arzaga, Xitlaly Judith Gonzalez Leal, Elías Eugenio Gonzalez-López, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 376.

https://doi.org/10.1182/blood-2024-208879

Published: 2024

Journal Articles

Efficacy of Outpatient Haploidentical Transplantation in Patients with Refractory Hodgkin Lymphoma

Ana Cristina Tejada Vasquez, César Homero Gutierrez-Aguirre, Luis Paulo Ugarte Pelaez, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Perla R. Rocio Colunga-Pedraza, Andres Gomez-De Leon, Olga Cantu, José Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 7395.

https://doi.org/10.1182/blood-2024-209003

Published: 2024

Journal Articles

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Alejandra De las Fuentes-Cepeda, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Michelle Morcos, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Antonio Vega Mateos, César Homero Gutierrez-Aguirre, Olga Cantu, Luz Tarin-Arzaga, Consuelo Mancías-Guerra, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles

Blood (2024) 144 (Supplement 1): 7299.

https://doi.org/10.1182/blood-2024-210921

Published: 2024

Journal Articles

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Luis Paulo Ugarte Pelaez, Yadith Karina Lopez-Garcia, Antonio Vega Mateos, Perla R. Colunga-Pedraza, Luz Tarin-Arzaga, Andres Gomez-De Leon, Olga Cantu, Jose Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 2364.

https://doi.org/10.1182/blood-2024-208836

Published: 2024

Journal Articles

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Yadith Karina Lopez-Garcia, Sara Redondo Velao, Andres Gomez-De Leon, Irene García-Cadenas, Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Albert Esquirol, César Homero Gutierrez-Aguirre, José Carlos Jaime-Pérez, Jorge Sierra, Olga Cantu, Javier Briones, David Gomez-Almaguer, Rodrigo Martino

Blood (2024) 144 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2024-210332

Published: 2024

Journal Articles

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Antonio Vega Mateos, Héctor Alejandro Vaquera Alfaro, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Olga Cantu, Andres Gomez-De Leon, David Gomez-Almaguer, Luz Tarin-Arzaga, César Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza

Blood (2024) 144 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2024-208831

Published: 2024

Journal Articles

Optimizing Conditioning Intensity to Disease Burden in Adults with Acute Myeloid Leukemia Undergoing Transplantation: Results of a Prospective Multicenter Study

Ana L. Varela-Constantino, Michelle Morcos, Andres Noyola-Perez, Nereida Méndez-Ramírez, Eli Fuentes-Chavez, Rosario Salazar-Riojas, César Homero Gutierrez-Aguirre, Olga Cantu, Perla Rocio Colunga Pedraza, Luz Tarin-Arzaga, Xitlaly Judith Gonzalez Leal, Elías Eugenio Gonzalez-López, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2024-211711

Published: 2024

Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 1711.

https://doi.org/10.1182/blood-2023-188171

Published: 2023

Journal Articles

CYP Inhibition and Low-Dose Dasatinib for Chronic Myeloid Leukemia: Preliminary Results of a Promising, Cost-Effective Treatment Option

Juan Francisco Barrios Ruiz, Fernando De La Garza, Victor Mingura Ledezma, Olga Cantu, Ana Cristina Tejada Vasquez, David Gomez-Almaguer, Perla R. Rocio Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 5744.

https://doi.org/10.1182/blood-2023-188215

Published: 2023

Journal Articles

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Julia Esther Colunga Pedraza, MD, Emmanuel Bugarin Estrada, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, José Miguel Yañez Reyes, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 3355.

https://doi.org/10.1182/blood-2018-99-116996

Published: 2018

Journal Articles

Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation

Andrés Gómez-De León, MD, Perla R Colunga Pedraza, MD, Diana E Garcia-Camarillo, MD, Roberto I. Vázquez-Garza, MD, Paola Santana-Hernandez, MD, Cesar Homero Gutierrez Aguirre, MD, Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 4602.

https://doi.org/10.1182/blood-2018-99-115420

Published: 2018

Journal Articles

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, Andres Gomez De Leon, MD, Diana E Garcia-Camarillo, MD, Oscar Marquez-Pinedo, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 1043.

https://doi.org/10.1182/blood-2018-99-118611

Published: 2018

Journal Articles

Supplementation with Selenium As Prevention for the Development of Mucositis in Patients Undergoing HSCT. Results of a Pilot Study

Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD, Cesar Homero Gutierrez Aguirre, MD, Consuelo Mancias, MD, Luz del Carmen Tarín Arzaga, MD, Andrés Gómez-De León, MD, Miguel Herrera-Rojas, MD, Lourdes Garza-Ocañas, MD, Jose Angel Hawing, MD

Blood (2018) 132 (Supplement 1): 3363.

https://doi.org/10.1182/blood-2018-99-119959

Published: 2018

Journal Articles

Low-Dose Plerixafor and Granulocyte Colony-Stimulating Factor for First-Line Autologous Peripheral Blood Stem Cell Mobilization in Lymphoma and Multiple Myeloma

Cesar Homero Gutierrez Aguirre, David Gomez-Almaguer, MD, Dalila Marisol Alvarado Navarro, MD, Rosario Salazar Riojas, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Gerardo Mejia Jaramillo, Guillermo Sotomayor Duque, MD, Andres Gomez De Leon, MD, Perla Rocio Colunga Pedraza, MD

Blood (2017) 130 (Supplement 1): 5459.

https://doi.org/10.1182/blood.V130.Suppl_1.5459.5459

Published: 2017

Journal Articles

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Perla Rocio Colunga Pedraza, MD, Andres Gomez De Leon, MD, Guillermo Sotomayor Duque, MD, Julia Esther Colunga Pedraza, MD, Yadith Karina López García, Paola Santana-Hernandez, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Oscar Gonzalez Llano, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 1940.

https://doi.org/10.1182/blood.V130.Suppl_1.1940.1940

Published: 2017

Journal Articles

Front-Line Treatment in Immune Thrombocytopenia Using Eltrombopag and High-Doses of Dexamethasone, Long-Term Follow-up

Olga Cantu Rodriguez, MD, Miguel Herrera-Rojas, MD, Andrea Garza-Acosta, MD, Cesar Homero Gutierrez Aguirre, Perla Rocio Colunga Pedraza, MD, Jose Jaime, MD, Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 4848.

https://doi.org/10.1182/blood.V130.Suppl_1.4848.4848

Published: 2017

Journal Articles

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Paola Santana-Hernandez, Perla Rocio Colunga Pedraza, MD, Guillermo Sotomayor Duque, MD, Andrés Gómez-De León, MD, Luz del Carmen Tarín Arzaga, MD, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 5254.

https://doi.org/10.1182/blood.V130.Suppl_1.5254.5254

Published: 2017

NARROW

Bioinformatic Evaluation of Molecular Differences in HLA-B and Their Effect on Graft-Versus-Host Disease in Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation from Related Donors

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Reassessing Blood Product Irradiation in Haploidentical Transplantation: A Single-Center Perspective

Lowering Conditioning Intensity in Fit Adolescents and Adults with Lymphoblastic Leukemia without Residual Disease Undergoing Transplantation: A Proof of Concept

Efficacy of Outpatient Haploidentical Transplantation in Patients with Refractory Hodgkin Lymphoma

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Optimizing Conditioning Intensity to Disease Burden in Adults with Acute Myeloid Leukemia Undergoing Transplantation: Results of a Prospective Multicenter Study

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

CYP Inhibition and Low-Dose Dasatinib for Chronic Myeloid Leukemia: Preliminary Results of a Promising, Cost-Effective Treatment Option

Cytokine Release Syndrome after Peripheral Blood T-Cell Replete Haploidentical Transplantation Is Not Prevented By Dexamethasone and Limits Its Full-Outpatient Conduction

Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Supplementation with Selenium As Prevention for the Development of Mucositis in Patients Undergoing HSCT. Results of a Pilot Study

Low-Dose Plerixafor and Granulocyte Colony-Stimulating Factor for First-Line Autologous Peripheral Blood Stem Cell Mobilization in Lymphoma and Multiple Myeloma

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Front-Line Treatment in Immune Thrombocytopenia Using Eltrombopag and High-Doses of Dexamethasone, Long-Term Follow-up

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only